Homeostasis and transitional activation of regulatory T cells require c-Myc.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31911938.
- Also identified by DOI 10.1126/sciadv.aaw6443 and PMC identifier 6938709.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Regulatory T cell (T<sub>reg</sub>) activation and expansion occur during neonatal life and inflammation to establish immunosuppression, yet the mechanisms governing these events are incompletely understood. We report that the transcriptional regulator c-Myc (Myc) controls immune homeostasis through regulation of T<sub>reg</sub> accumulation and functional activation. Myc activity is enriched in T<sub>regs</sub> generated during neonatal life and responding to inflammation. Myc-deficient T<sub>regs</sub> show defects in accumulation and ability to transition to an activated state. Consequently, loss of Myc in T<sub>regs</sub> results in an early-onset autoimmune disorder accompanied by uncontrolled effector CD4<sup>+</sup> and CD8<sup>+</sup> T cell responses. Mechanistically, Myc regulates mitochondrial oxidative metabolism but is dispensable for fatty acid oxidation (FAO). Indeed, T<sub>reg</sub>-specific deletion of Cox10, which promotes oxidative phosphorylation, but not Cpt1a, the rate-limiting enzyme for FAO, results in impaired T<sub>reg</sub> function and maturation. Thus, Myc coordinates T<sub>reg</sub> accumulation, transitional activation, and metabolic programming to orchestrate immune homeostasis.
Medical subject headings
- Fatty Acids
- Immunosuppression Therapy
- Inflammation
- Proto-Oncogene Proteins c-myc
- T-Lymphocytes, Regulatory